The AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.76% dropped 0.66% to $58.74 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.05% rising 1.02% to 14,896.85 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% rising 1.00% to 34,258.32. The ADR's fall snapped a two-day winning streak. AstraZeneca PLC ADR closed $2.19 short of its 52-week high ($60.93), which the company achieved on July 12th.
The ADR demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.89% fell 0.69% to $106.41, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.39% fell 0.80% to $213.64, and Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD -0.06% fell 0.49% to $71.38. Trading volume (6.4 M) remained 4.7 million below its 50-day average volume of 11.1 M.